Deficiencies in addressing effect modification in network meta-analyses: a meta-epidemiological survey.
暂无分享,去创建一个
Kristian Thorlund | Lehana Thabane | K. Thorlund | L. Thabane | Bruno Kovic | Camila Silvestre | M. Zoratti | Michael J Zoratti | Steven Michalopoulos | S. Michalopoulos | B. Kovic | Camila Silvestre
[1] Chris Cameron,et al. Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis , 2013, BMJ.
[2] B. V. Van Tassell,et al. Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis , 2013, BMJ.
[3] P. Royle,et al. Denosumab for treatment of bone metastases secondary to solid tumours: systematic review and network meta-analysis. , 2013, European journal of cancer.
[4] K. Boye,et al. A network meta‐analysis to compare glycaemic control in patients with type 2 diabetes treated with exenatide once weekly or liraglutide once daily in comparison with insulin glargine, exenatide twice daily or placebo , 2013, Diabetes, obesity & metabolism.
[5] David C Hoaglin,et al. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[6] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[7] K. Thorlund,et al. Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis , 2012, QJM : monthly journal of the Association of Physicians.
[8] M. Orme,et al. The Efficacy and Safety of Oral Anticoagulants in Warfarin-Suitable Patients With Nonvalvular Atrial Fibrillation , 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[9] N. Freemantle,et al. Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. , 2013, The Journal of thoracic and cardiovascular surgery.
[10] G. Rücker,et al. Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. , 2013, JAMA internal medicine.
[11] Huseyin Naci,et al. Comparative Tolerability and Harms of Individual Statins: A Study-Level Network Meta-Analysis of 246 955 Participants From 135 Randomized, Controlled Trials , 2013, Circulation. Cardiovascular quality and outcomes.
[12] B. Djulbegovic,et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review , 2003, BMJ : British Medical Journal.
[13] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.
[14] Joseph C Cappelleri,et al. Indirect treatment comparison/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[15] T. Trikalinos,et al. Comparative efficacy of first-line therapies for advanced-stage chronic lymphocytic leukemia: a multiple-treatment meta-analysis. , 2013, Cancer treatment reviews.
[16] Philippe Charlier,et al. Which placebo to cure depression? A thought-provoking network meta-analysis , 2013, BMC Medicine.
[17] M. Büchler,et al. ENERgized vessel sealing systems versus CONventional hemostasis techniques in thyroid surgery—the ENERCON systematic review and network meta-analysis , 2013, Langenbeck's Archives of Surgery.
[18] Sergio Sismondo,et al. Industry sponsorship and research outcome. , 2012, The Cochrane database of systematic reviews.
[19] Janet E Brown,et al. Comparative Efficacy of Bisphosphonates in Metastatic Breast and Prostate Cancer and Multiple Myeloma: A Mixed-Treatment Meta-analysis , 2013, Clinical Cancer Research.
[20] A. Darzi,et al. Which hemostatic device in thyroid surgery? A network meta-analysis of surgical technologies. , 2013, Thyroid : official journal of the American Thyroid Association.
[21] D. Hoaglin,et al. Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding , 2013, European Journal of Medical Research.
[22] G. Biondi‐Zoccai,et al. New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation. , 2013, JAMA neurology.
[23] Lei Wang,et al. Comparative Efficacy and Acceptability of Antidepressants in Parkinson's Disease: A Network Meta-Analysis , 2013, PloS one.
[24] G. Bakalos,et al. A network meta‐analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis , 2013, Journal of clinical pharmacy and therapeutics.
[25] G. Biondi-Zoccai,et al. Anaesthetic Drugs and Survival: A Bayesian Network Meta-analysis of Randomized Trials in Cardiac Surgery , 2014 .
[26] N. Hawkins,et al. The relative efficacy of imatinib, dasatinib and nilotinib for newly diagnosed chronic myeloid leukemia: a systematic review and network meta-analysis , 2013, Experimental Hematology & Oncology.
[27] B. Duncan,et al. Impact of statin dose on major cardiovascular events: a mixed treatment comparison meta-analysis involving more than 175,000 patients. , 2013, International journal of cardiology.
[28] G. Dranitsaris,et al. Small molecule targeted therapies for the second-line treatment for metastatic renal cell carcinoma: a systematic review and indirect comparison of safety and efficacy , 2013, Journal of Cancer Research and Clinical Oncology.
[29] R. Pontarolo,et al. Insulin analogues versus human insulin in type 1 diabetes: direct and indirect meta-analyses of efficacy and safety , 2013 .
[30] G. Stone,et al. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. , 2013, Journal of the American College of Cardiology.
[31] K. Ellenbogen,et al. Comparative effectiveness of novel oral anticoagulants for atrial fibrillation: evidence from pair-wise and warfarin-controlled network meta-analyses , 2013, HSR proceedings in intensive care & cardiovascular anesthesia.
[32] N. Hawkins,et al. The efficacy and tolerability of perampanel and other recently approved anti-epileptic drugs for the treatment of refractory partial onset seizure: a systematic review and Bayesian network meta-analysis , 2013, Current Medical Research and Opinion.
[33] S. de Servi,et al. Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. , 2013, The American journal of cardiology.
[34] R. Perera,et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. , 2013, The Cochrane database of systematic reviews.
[35] P. Cuijpers,et al. Comparative Efficacy of Seven Psychotherapeutic Interventions for Patients with Depression: A Network Meta-Analysis. , 2016, Focus.
[36] Alex J. Sutton,et al. Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment , 2011 .
[37] A. Goralczyk,et al. Treatment of chronic HCV genotype 1 infection with telaprevir: a Bayesian mixed treatment comparison of fixed-length and response-guided treatment regimens in treatment-naïve and –experienced patients , 2013, BMC Gastroenterology.
[38] M. Zheng,et al. Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple‐treatments meta‐analysis , 2013, European journal of clinical investigation.
[39] V. Diehl,et al. Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis. , 2013, The Lancet. Oncology.
[40] H. Naci,et al. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials , 2013, European journal of preventive cardiology.
[41] M. Hochberg,et al. Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis , 2013, Current medical research and opinion.
[42] G. Stone,et al. Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: Evidence from a comprehensive network meta-analysis. , 2013, American heart journal.
[43] Georgia Salanti,et al. Indirect and mixed‐treatment comparison, network, or multiple‐treatments meta‐analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool , 2012, Research synthesis methods.
[44] Joseph C Cappelleri,et al. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[45] A. Messori,et al. New and old anti-thrombotic treatments for patients with atrial fibrillation , 2013, International Journal of Clinical Pharmacy.
[46] Wei-Chih Liao,et al. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis , 2013, BMJ.
[47] C. Di Pietrantonj,et al. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis. , 2013, The Cochrane database of systematic reviews.
[48] H. Naci,et al. Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials , 2013, European journal of preventive cardiology.
[49] C. A. Jones,et al. Efficacy of supplemental peripheral nerve blockade for hip fracture surgery: multiple treatment comparison , 2013, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.
[50] D. Mukherjee,et al. Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis , 2013, Journal of Thrombosis and Thrombolysis.
[51] J. Donovan,et al. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis. , 2013, Clinical therapeutics.
[52] M. Paquet,et al. Network meta‐analysis of the outcome ‘participant complete clearance’ in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow‐up on a Cochrane review , 2013, The British journal of dermatology.
[53] L. Smeeth,et al. Comparative efficacy and tolerability of anti‐epileptic drugs for refractory focal epilepsy: systematic review and network meta‐analysis reveals the need for long term comparator trials , 2013, British journal of clinical pharmacology.
[54] K. Chien,et al. In-office treatment for dentin hypersensitivity: a systematic review and network meta-analysis. , 2013, Journal of clinical periodontology.
[55] M. K. Siddiqui,et al. Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses , 2013, Open access rheumatology : research and reviews.
[56] G. Zaccara,et al. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine , 2013, Seizure.
[57] N. Freemantle,et al. Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis , 2012, Osteoporosis International.
[58] S. Fénix-Caballero,et al. Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis , 2013, Journal of clinical pharmacy and therapeutics.
[59] M. Baccini,et al. Bayesian network meta-analysis of root coverage procedures: ranking efficacy and identification of best treatment. , 2013, Journal of clinical periodontology.
[60] Peter Jüni,et al. Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis , 2012, Annals of the rheumatic diseases.
[61] M. Pedroso,et al. Comparative Efficacy of Oral Nucleoside or Nucleotide Analog Monotherapy Used in Chronic Hepatitis B: A Mixed‐Treatment Comparison Meta‐analysis , 2013, Pharmacotherapy.
[62] A. Sutton,et al. Acupuncture and other physical treatments for the relief of pain due to osteoarthritis of the knee: network meta-analysis☆ , 2013, Osteoarthritis and cartilage.
[63] Atle Fretheim,et al. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. , 2013, The Cochrane database of systematic reviews.
[64] D. Wonderling,et al. Topical therapies for the treatment of plaque psoriasis: systematic review and network meta‐analyses , 2013, The British journal of dermatology.
[65] A. Bhansali,et al. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis. , 2013, Pain physician.
[66] A. Messori,et al. New endovascular devices for acute ischemic stroke: summarizing evidence by multiple treatment comparison meta-analysis. , 2013, Annals of vascular surgery.
[67] Shaona Niu,et al. Lenalidomide versus thalidomide based regimens as first-line therapy for patients with multiple myeloma , 2013, Leukemia & lymphoma.
[68] O. Uthman,et al. Exercise for lower limb osteoarthritis: systematic review incorporating trial sequential analysis and network meta-analysis , 2013, BMJ : British Medical Journal.
[69] Wei-Chih Liao,et al. Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. , 2013, The Lancet. Oncology.
[70] H. Suryapranata,et al. Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis , 2013, BMJ.
[71] Jack Y. B. Lee,et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. , 2013, European urology.
[72] E. Huisman,et al. Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis , 2013, International journal of chronic obstructive pulmonary disease.
[73] M. Bennett,et al. Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials. , 2013, Journal of pain and symptom management.
[74] J. Dumville,et al. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. , 2013, The Cochrane database of systematic reviews.
[75] M. Kraemer,et al. Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis , 2013, Respiratory Research.
[76] Philippe Ravaud,et al. Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review , 2013, BMJ.
[77] B. Riveros,et al. Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments. , 2013, JAMA dermatology.
[78] N. Hawkins,et al. A comparison of national guidelines for network meta-analysis. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[79] M. Barry,et al. The relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[80] L. Rong,et al. Indirect comparison of anti-TNF-α agents for active ankylosing spondylitis: mixed treatment comparison of randomized controlled trials. , 2013, Clinical and experimental rheumatology.
[81] J. Jansen,et al. Progression-free survival with fulvestrant 500 mg and alternative endocrine therapies as second-line treatment for advanced breast cancer: a network meta-analysis with parametric survival models. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[82] Hsien-Ho Lin,et al. Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials , 2012, Thorax.